Personalised therapeutic approaches to glioblastoma: A systematic review
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1166104
Abstract: Introduction Glioblastoma is the most common and malignant primary brain tumour with median survival of 14.6 months. Personalised medicine aims to improve survival by targeting individualised patient characteristics. However, a major limitation has been application… read more here.
Keywords: glioblastoma systematic; personalised therapeutic; systematic review; therapeutic approaches ... See more keywords
Immunotherapeutic Approaches for Glioblastoma Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10020427
Abstract: Glioblastoma remains a challenging disease to treat, despite well-established standard-of-care treatments, with a median survival consistently of less than 2 years. In this review, we delineate the unique disease-specific challenges for immunotherapies, both brain-related and… read more here.
Keywords: glioblastoma treatment; approaches glioblastoma; immunotherapeutic approaches;